Xeris Biopharma Holdings, Inc. Common Stock (XERS) Stock Price

XERSStock

$8.74+12.77%52W

Market Cap$1.59B

P/E2645.72x

PEG Ratio—

Div yield—

Beta0.71

XERS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)13.08%

Price vs S&P 500 (4W)3.02%

VGM Score58.36

P/E Ratio (Annual)2645.72x

P/CF (Annual)51.20x

Book Value / Share (Quarterly)$0.08

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)38.35%

Cash Flow / Share (Quarterly)$0.28

Price vs S&P 500 (YTD)-0.62%

Gross Margin (TTM)85.89%

Net Profit Margin (TTM)3.81%

EPS (TTM)$0.06

10-Day Avg Trading Volume1.69M

EPS Excl Extra (TTM)$0.06

Revenue Growth (5Y)70.26%

EPS (Annual)$0.00

ROI (Annual)0.24%

Gross Margin (Annual)85.41%

Net Profit Margin (5Y Avg)-79.62%

Cash / Share (Quarterly)$0.65

P/E Basic Excl Extra (TTM)122.06x

Revenue Growth QoQ (YoY)38.27%

P/E Normalized (Annual)2645.72x

ROA (Last FY)0.14%

Revenue Growth TTM (YoY)41.47%

EBITD / Share (TTM)$0.26

ROE (5Y Avg)-295.22%

Operating Margin (TTM)11.40%

Cash Flow / Share (Annual)$0.17

P/B Ratio112.65x

P/B Ratio (Quarterly)76.87x

Net Income / Employee (Annual)$1,300

EV / Revenue (TTM)5.00x

Net Interest Coverage (TTM)1.02x

ROA (TTM)3.24%

EV / EBITDA (TTM)33.70x

EPS Incl Extra (Annual)$0.00

Current Ratio (Annual)2.19x

Quick Ratio (Quarterly)1.42x

3-Month Avg Trading Volume1.81M

52-Week Price Return12.77%

EV / Free Cash Flow (Annual)56.40x

P/E Incl Extra (TTM)122.06x

Revenue / Employee (TTM)$723,800

Tangible BV / Share (Quarterly)$-0.95

P/S Ratio (Annual)5.02x

Asset Turnover (Annual)0.76x

52-Week High$10.08

Operating Margin (5Y Avg)-69.12%

EPS Excl Extra (Annual)$0.00

CapEx CAGR (5Y)12.87%

26-Week Price Return24.32%

Quick Ratio (Annual)1.48x

13-Week Price Return36.99%

Total Debt / Equity (Annual)16.10x

Current Ratio (Quarterly)2.12x

Enterprise Value$1.58B

Revenue / Share Growth (5Y)28.68%

Asset Turnover (TTM)0.85x

Book Value / Share Growth (5Y)-53.08%

Revenue / Employee (Annual)$670,900

Inventory Turnover (Annual)0.73x

Pretax Margin (Annual)0.19%

Cash / Share (Annual)$0.67

3-Month Return Std Dev44.53%

Gross Margin (5Y Avg)80.49%

Net Income / Employee (TTM)$27,600

ROE (Last FY)4.05%

Net Interest Coverage (Annual)1.50x

EPS Basic Excl Extra (Annual)$0.00

P/FCF (TTM)30.78x

Receivables Turnover (TTM)6.14x

EV / Free Cash Flow (TTM)33.15x

Total Debt / Equity (Quarterly)17.00x

EPS Incl Extra (TTM)$0.06

Receivables Turnover (Annual)6.38x

ROI (TTM)5.69%

P/S Ratio (TTM)4.66x

Pretax Margin (5Y Avg)-80.25%

Revenue / Share (Annual)$1.69

Tangible BV / Share (Annual)$-0.72

Forward P/E37.05x

Price vs S&P 500 (52W)-5.54%

P/E Ratio (TTM)122.06x

Year-to-Date Return11.34%

5-Day Price Return-1.24%

EPS Normalized (Annual)$0.00

ROA (5Y Avg)-20.79%

Net Profit Margin (Annual)0.19%

Month-to-Date Return8.17%

Cash Flow / Share (TTM)$-0.36

EBITD / Share (Annual)$0.21

Operating Margin (Annual)8.53%

LT Debt / Equity (Annual)16.10x

P/CF (TTM)30.20x

ROI (5Y Avg)-71.13%

P/E Excl Extra (TTM)122.06x

LT Debt / Equity (Quarterly)17.00x

EPS Basic Excl Extra (TTM)$0.06

P/B Ratio (Annual)97.76x

Inventory Turnover (TTM)0.70x

Pretax Margin (TTM)3.81%

Book Value / Share (Annual)$0.08

Price vs S&P 500 (13W)34.20%

Beta0.71x

P/FCF (Annual)52.48x

Revenue / Share (TTM)$1.77

ROE (TTM)99.74%

52-Week Low$5.25

vGradeD

gGradeA

mGradeB

vgmGradeC

XERS Earnings Surprise History

Q2 25-0.01est. -0.03

Q3 250.00est. 0.00

Q4 250.06est. 0.04

Q1 260.01est. -0.00

Q2 26-0.00est. 0.00

XERS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.23

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
XERSXeris Biopharma Holdings, Inc. Common Stock	D	A	B	$8.74
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Xeris Biopharma Holdings, Inc. Common Stock

Xeris Biopharma is a commercial-stage biopharmaceutical company specializing in treatments for chronic endocrine and neurological diseases. The company markets three FDA-approved therapies: Recorlev for Cushing's syndrome, Gvoke for severe hypoglycemia, and Keveyis for Primary Periodic Paralysis. Its Phase 3-ready pipeline includes XP-8121, a once-weekly subcutaneous levothyroxine injection leveraging the company's proprietary XeriSol technology.